SCHEMBL255481

SCHEMBL255481

CCC(c1ccc(F)cc1)c1nc(Nc2cc(C)[nH]n2)c2ccccc2n1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.76
CYP3A4 P08684 3/20 0.76
CYP2C8 P10632 3/20 0.76
CYP2C9 P11712 3/20 0.76
JAK1 P23458 3/20 0.76
TYK2 P29597 3/20 0.76
CYP2C19 P33261 3/20 0.76
JAK3 P52333 3/20 0.76
ADORA3 P0DMS8 2/20 0.76
CYP1A2 P05177 1/20 0.76
AURKA O14965 8/20 0.67
AURKB Q96GD4 5/20 0.67
NTRK1 P04629 7/20 0.63
SRC P12931 3/20 0.59
GSK3B P49841 3/20 0.59
EIF2AK2 P19525 1/20 0.59
GSK3A P49840 1/20 0.59
GRK6 P43250 2/20 0.57
NTRK3 Q16288 1/20 0.56
NTRK2 Q16620 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15434611 1.00 JAK2 (0.76) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL10272395 0.91 JAK2 (0.74) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL255837 0.91 JAK2 (0.78) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL174560 0.89 JAK2 (0.72) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL255912 0.89 JAK2 (0.72) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL174533 0.88 JAK2 (0.71) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL174168 0.88 JAK2 (0.71) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL255855 0.88 JAK2 (0.71) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL255825 0.88 JAK2 (0.71) JAK2CYP3A4CYP2C8CYP2C9JAK1
SCHEMBL256446 0.87 JAK2 (0.79) JAK2CYP3A4CYP2C8CYP2C9JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030918-A1 ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed